Skip to main content
Top
Published in: BMC Gastroenterology 1/2004

Open Access 01-12-2004 | Research article

Child-Pugh classification dependent alterations in serum leptin levels among cirrhotic patients: a case controlled study

Authors: Fusun F Bolukbas, Cengiz Bolukbas, Mehmet Horoz, Mahmut Gumus, Mehmet Erdogan, Fadile Zeyrek, Ali Yayla, Oya Ovunc

Published in: BMC Gastroenterology | Issue 1/2004

Login to get access

Abstract

Background

As anorexia and hypermetabolism are common in cirrhosis, leptin levels may be increased in this disease. In this study, we investigated the relation between the severity of disease and serum leptin levels in post-hepatitis cirrhosis and the role of body composition, gender and viral aetiology of cirrhosis in this association.

Methods

Thirty-five cases with post-hepatitis cirrhosis and 15 healthy controls were enrolled in this study. Body composition including body mass index, body fat percentage and body fat mass were determined. Serum leptin levels were assayed.

Results

Leptin levels were significantly higher among cirrhotic patients independent of sex compared to controls (p = 0.001). Female patients in both groups have had higher leptin levels than males (in cirrhotics p = 0.029, in controls p = 0.02).
Cirrhotic patients in each of A, B and C subgroups according to the Child- Pugh classification revealed significantly different levels compared to controls (p = 0.046, p = 0.004, p = 0.0001, respectively). Male cirrhotics in Child-Pugh Class B and C subgroups had significantly higher leptin levels compared to male controls (p = 0.006, p = 0.008). On the other hand, female patients only in Child Pugh class C subgroup have had higher levels of serum leptin compared to controls (p = 0.022).
Child-Pugh classification has been found to be the sole discriminator in determination of leptin levels in cirrhotics by linear regression (beta: 0.435 p = 0.015).

Conclusion

Serum leptin levels increase in advanced liver disease independently of gender, body composition in posthepatitic cirrhosis. The increase is more abundant among patients that belong to C subgroup according to the Child- Pugh classification.
Appendix
Available only for authorised users
Literature
1.
go back to reference Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV: Leptin: the tale of an obesity gene. Diabetes. 1996, 45 (11): 1455-1462.CrossRefPubMed Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV: Leptin: the tale of an obesity gene. Diabetes. 1996, 45 (11): 1455-1462.CrossRefPubMed
2.
go back to reference Friedman JM: Leptin, leptin receptors and control of body weight. Eur J Med Res. 1997, 2 (1): 7-13.PubMed Friedman JM: Leptin, leptin receptors and control of body weight. Eur J Med Res. 1997, 2 (1): 7-13.PubMed
3.
go back to reference Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT: The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensivity, and energy expenditure. J Clin Endocrinol Metab. 1997, 82 (4): 1293-1300. 10.1210/jc.82.4.1293.PubMed Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT: The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensivity, and energy expenditure. J Clin Endocrinol Metab. 1997, 82 (4): 1293-1300. 10.1210/jc.82.4.1293.PubMed
4.
go back to reference Levin N, Nelson C, Gurney A, Vandlen R, De Sauvage F: Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA. 1996, 93 (4): 1726-1730. 10.1073/pnas.93.4.1726.CrossRefPubMedPubMedCentral Levin N, Nelson C, Gurney A, Vandlen R, De Sauvage F: Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA. 1996, 93 (4): 1726-1730. 10.1073/pnas.93.4.1726.CrossRefPubMedPubMedCentral
5.
go back to reference Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TR, Caro JF: Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Engl J Med. 1996, 334 (5): 292-295. 10.1056/NEJM199602013340503.CrossRefPubMed Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TR, Caro JF: Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Engl J Med. 1996, 334 (5): 292-295. 10.1056/NEJM199602013340503.CrossRefPubMed
6.
go back to reference Fruhbeck G, Jebb SA, Prientice AM: Leptin: physiology and pathophysiology. Clin Physiol. 1998, 18 (5): 399-419. 10.1046/j.1365-2281.1998.00129.x.CrossRefPubMed Fruhbeck G, Jebb SA, Prientice AM: Leptin: physiology and pathophysiology. Clin Physiol. 1998, 18 (5): 399-419. 10.1046/j.1365-2281.1998.00129.x.CrossRefPubMed
7.
go back to reference Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nature Med. 1995, 1 (11): 1155-1161. 10.1038/nm1195-1155.CrossRefPubMed Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nature Med. 1995, 1 (11): 1155-1161. 10.1038/nm1195-1155.CrossRefPubMed
8.
go back to reference Muller MJ: Malnutrition in cirrhosis. J Hepatol. 1995, 23 (suppl 1): 31-35.PubMed Muller MJ: Malnutrition in cirrhosis. J Hepatol. 1995, 23 (suppl 1): 31-35.PubMed
9.
go back to reference McCullough AJ, Raguso C: Effect of cirrhosis on energy expenditure. Am J Clin Nutr. 1999, 69 (6): 1066-1068.PubMed McCullough AJ, Raguso C: Effect of cirrhosis on energy expenditure. Am J Clin Nutr. 1999, 69 (6): 1066-1068.PubMed
10.
go back to reference Ockenga J, Bischoff SC, Tillmann HL, Rifai K, Widjaja A, Boker KH, Manns MP, Brabant G: Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology. 2000, 119 (6): 1656-1662.CrossRefPubMed Ockenga J, Bischoff SC, Tillmann HL, Rifai K, Widjaja A, Boker KH, Manns MP, Brabant G: Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology. 2000, 119 (6): 1656-1662.CrossRefPubMed
11.
go back to reference McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC: Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology. 1998, 115 (4): 947-953.CrossRefPubMed McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC: Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology. 1998, 115 (4): 947-953.CrossRefPubMed
12.
go back to reference Greco AV, Mingrone G, Favuzzi A, Capristo E, Gniuli D, Addolorato G, Brunani A, Cavagnin F, Gasbarrini G: Serum leptin levels in post-hepatitis liver cirrhosis. J Hepatol. 2000, 33 (1): 38-42. 10.1016/S0168-8278(00)80157-9.CrossRefPubMed Greco AV, Mingrone G, Favuzzi A, Capristo E, Gniuli D, Addolorato G, Brunani A, Cavagnin F, Gasbarrini G: Serum leptin levels in post-hepatitis liver cirrhosis. J Hepatol. 2000, 33 (1): 38-42. 10.1016/S0168-8278(00)80157-9.CrossRefPubMed
13.
go back to reference Testa R, Franceschini R, Giannini E, Cataldi A, Botta F, Fasoli A, Tenerelli P, Rolandi E, Barreca T: Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol. 2000, 33 (1): 33-37. 10.1016/S0168-8278(00)80156-7.CrossRefPubMed Testa R, Franceschini R, Giannini E, Cataldi A, Botta F, Fasoli A, Tenerelli P, Rolandi E, Barreca T: Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol. 2000, 33 (1): 33-37. 10.1016/S0168-8278(00)80156-7.CrossRefPubMed
14.
go back to reference Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the esophagus for bleeding esoghageal varices. Br J Surg. 1973, 60 (8): 646-649.CrossRefPubMed Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the esophagus for bleeding esoghageal varices. Br J Surg. 1973, 60 (8): 646-649.CrossRefPubMed
15.
go back to reference Heymsfield SB, Williams PJ: Nutritional assessment by clinical and biochemical methods. In Modern Nutrition in Health and Disease. Edited by: Shils ME, Young VR. 1988, Philadelphia: Lea & Febiger, 817-860. 7 Heymsfield SB, Williams PJ: Nutritional assessment by clinical and biochemical methods. In Modern Nutrition in Health and Disease. Edited by: Shils ME, Young VR. 1988, Philadelphia: Lea & Febiger, 817-860. 7
16.
go back to reference Jackson AS, Pollock ML, Ward A: Generalized equations for predicting body density of women. Med Sci Sports Exerc. 1980, 12 (3): 175-181.CrossRefPubMed Jackson AS, Pollock ML, Ward A: Generalized equations for predicting body density of women. Med Sci Sports Exerc. 1980, 12 (3): 175-181.CrossRefPubMed
17.
go back to reference Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW: Energy expenditure and substrate oxidation in patients with cirrhosis: the impact cause, clinical staging and nutritional state. Hepatology. 1992, 15 (5): 782-794.CrossRefPubMed Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW: Energy expenditure and substrate oxidation in patients with cirrhosis: the impact cause, clinical staging and nutritional state. Hepatology. 1992, 15 (5): 782-794.CrossRefPubMed
18.
go back to reference McCullough AJ, Mullen KD, Kalhan SC: Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology. 1991, 14 (6): 1102-1111. 10.1016/0270-9139(91)90136-J.CrossRefPubMed McCullough AJ, Mullen KD, Kalhan SC: Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology. 1991, 14 (6): 1102-1111. 10.1016/0270-9139(91)90136-J.CrossRefPubMed
19.
go back to reference Guechot J, Chazouilleres O, Loria A, Hannoun L, Balladur P, Parc R, Giboudeau J, Poupon R: Effect of liver transplantation on sex-hormone disorders in male patients with alcohol-induced or post-viral hepatitis advanced liver disease. J Hepatol. 1994, 20 (3): 426-430.CrossRefPubMed Guechot J, Chazouilleres O, Loria A, Hannoun L, Balladur P, Parc R, Giboudeau J, Poupon R: Effect of liver transplantation on sex-hormone disorders in male patients with alcohol-induced or post-viral hepatitis advanced liver disease. J Hepatol. 1994, 20 (3): 426-430.CrossRefPubMed
20.
go back to reference Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F: Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal. Hepatology. 1999, 29 (6): 1818-1824. 10.1002/hep.510290601.CrossRefPubMed Henriksen JH, Holst JJ, Moller S, Brinch K, Bendtsen F: Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal. Hepatology. 1999, 29 (6): 1818-1824. 10.1002/hep.510290601.CrossRefPubMed
21.
go back to reference Lin HZ, Yang SQ, Zeldin G, Diehl AM: Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res. 1998, 22 (5 Suppl): 231S-237S.CrossRefPubMed Lin HZ, Yang SQ, Zeldin G, Diehl AM: Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res. 1998, 22 (5 Suppl): 231S-237S.CrossRefPubMed
22.
Metadata
Title
Child-Pugh classification dependent alterations in serum leptin levels among cirrhotic patients: a case controlled study
Authors
Fusun F Bolukbas
Cengiz Bolukbas
Mehmet Horoz
Mahmut Gumus
Mehmet Erdogan
Fadile Zeyrek
Ali Yayla
Oya Ovunc
Publication date
01-12-2004
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2004
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-4-23

Other articles of this Issue 1/2004

BMC Gastroenterology 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.